New study sug­gests it costs $1.3B in R&D in­vest­ment to bring a drug to mar­ket. How did it get there?

Politi­cians, pun­dits and pa­tient groups now have a new num­ber at their dis­pos­al when drug­mak­ers cite high R&D costs — as much as $2.8 bil­lion in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.